Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clonidine for postoperative nausea and vomiting in breast cancer surgery
IRCT20141009019470N99Phase 3Completed
- Sponsor
- Shiraz University of Medical Sciences
- Start
- Jul 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of clonidine in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Shiraz University of Medical Sciences. Primary endpoints: Post-operative nausea and vomiting and Hemodynamic changes. Started Jul 2020; status: completed.
02
Drugs
clonidine
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20141009019470N99.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20141009019470N99.